2 completed. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow SUGEN: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma SU5416 - Sarcoma, Kaposi, HIV Infections | Not applicable | Completed | SUGEN | 30 | 2005-06-24 | |
| SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment SU5416 - Sarcoma, Kaposi, HIV Infections | Phase 2 | Completed | SUGEN | 30 | 2005-06-24 |
HIV Infections (2) · Sarcoma, Kaposi (2) · Skin Neoplasms (2) · Acquired Immunodeficiency Syndrome (1)
Semaxinib (2)
United States (2)